TITLE

A Comprehensive Medicine Approach to Migraines

AUTHOR(S)
Thitelbaum, Jacob
PUB. DATE
January 2005
SOURCE
Townsend Letter for Doctors & Patients;Jan2005, Issue 258, p40
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
This article presents a comprehensive medicine approach to migraines. There is still marked debate over the cause of migraines. For decades, researchers thought that these occurred because of excessive contraction and expansion of the blood vessels in the brain. Others thought that this blood vessel problem occurred because of inadequate serotonin, the neurotransmitter that controls sleep and mood, which also ptays a role in how blood vessels expand. Low serotonin also amplifies pain by increasing the pain neurotransmitter called substance P. Muscle spasm and nutritional imbalances and deficiencies can also contribute to migraines, as can food sensitivities.
ACCESSION #
15508652

 

Related Articles

  • zolmitriptan. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p814 

    A definition of the term "zolmitriptan" is presented. It refers to a serotonin agonist used for treating acute attacks of migraine.

  • Consider the risk of potential drug interactions when co-prescribing triptans with other medications.  // Drugs & Therapy Perspectives;May2013, Vol. 29 Issue 5, p151 

    Triptans generally have a low potential for drug interactions, with pharmacodynamic interactions likely to be of greater clinical significance than pharmacokinetic interactions. The most notable pharmacodynamic interactions include additive vasoconstrictor effects (e.g. with concomitant ergots)...

  • 5HT1F- and 5HT7-Receptor Agonists for the Treatment of Migraines. Agosti, Reto M. // CNS & Neurological Disorders - Drug Targets;2007, Vol. 6 Issue 4, p235 

    Serotonin was the first neurotransmitter believed to be involved in cephalic pain transfer forward to the cortex, but the precise mechanism was confirmed only after sumatriptan, a 5-HT1B/1D high affinity agonist, was introduced in the acute treatment of migraine. Although very efficient for...

  • PAIN.  // Current Medical Literature: Neurology;2005, Vol. 21 Issue 4, p87 

    The article presents comments by clinicians on two studies about pain. They include "Selective serotonin re-uptake inhibitors for preventing migraine and tension-type headaches" and "Cluster headache: pathogenesis, diagnosis, and management."

  • pizotifen.  // Royal Society of Medicine: Medicines;2002, p442 

    The article presents information on pizotifen which is an antihistamine and serotonin antagonist that can be used as an antimigraine treatment for migraine and cluster headaches. The drug's administration is oral. Side effects include anticholinergic effects, drowsiness, increased appetite and...

  • Sumatriptan: An Updated Review of its Use in Migraine. Perry, C.M.; Markham, A. // Drugs;Jun1998, Vol. 55 Issue 6, p889 

    Sumatriptan is a selective agonist at serotonin 5-HT-like receptors, including 5-HT subtypes. It is an effective treatment for acute migraine attacks and the injectable form has also shown efficacy in the treatment of cluster headaches. In placebo-controlled clinical trials, sumatriptan,...

  • Can we Develop Neurally Acting Drugs for the Treatment of Migraine? Goadsby, Peter J. // Nature Reviews Drug Discovery;Sep2005, Vol. 4 Issue 9, p741 

    Serotonin (5-HT)1B/1D receptor agonists, which are also known as triptans, represent the most important advance in migraine therapeutics in the four millennia that the condition has been recognized. The vasoconstrictive activity of triptans produced a small clinical penalty in terms of coronary...

  • Headache. Kernick, David // Update;Jan2007, Vol. 74 Issue 1, p16 

    The article provides an overview on headache as well as the key areas of progress in headache care. It states that headache is classified as primary, if there is no identifiable cause, or secondary, when an underlying cause is known. Key information is presented which outlines the categories of...

  • Upcoming drugs for migraine. Sharma, T.; Dutta, S. B.; Dhasmana, D. C.; Mishra, K. C. // Indian Journal of Pharmacology;Jun2004, Vol. 36 Issue 3, p188 

    Offers information on several triptan drugs developed for migraine, which target 5HT receptors. Almotriptan; Rizatriptan; Zolmitriptan; Frovatriptan.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics